Preetam Shah
Director of Finance/CFO chez CIDARA THERAPEUTICS, INC.
Fortune : 309 083 $ au 31/03/2024
Profil
Preetam Shah is the founder of Saisarva LLC, which was founded in 2010.
Currently, Dr. Shah is the Chief Financial, Accounting & Business Officer at Cidara Therapeutics, Inc. since 2022.
Previously, Dr. Shah held positions as Director-Healthcare Investment Banking at Barclays Capital, Inc. and Lordes Capital Ltd.
From 2019 to 2021, Dr. Shah served as the Chief Financial Officer, Treasurer & Executive VP at Brainstorm Cell Therapeutics, Inc. From 2013 to 2016, Dr. Shah worked as the Vice President-Healthcare Investment Banking at Canaccord Genuity, Inc. Prior to that, from 2006 to 2009, Dr. Shah was the Vice President-U.S.
Operations & Investments at Reliance Capital Usa Ventures LLC.
Dr. Shah holds a doctorate degree from the University of Mississippi Medical Center and an MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2024 | 335 960 ( 0,37% ) | 309 083 $ | 31/03/2024 |
Postes actifs de Preetam Shah
| Sociétés | Poste | Début |
|---|---|---|
| CIDARA THERAPEUTICS, INC. | Director of Finance/CFO | 01/09/2021 |
Anciens postes connus de Preetam Shah
| Sociétés | Poste | Fin |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Director of Finance/CFO | 31/08/2021 |
Canaccord Genuity, Inc.
 Canaccord Genuity, Inc. Investment Banks/BrokersFinance Founded in 2006, Canaccord Genuity, Inc. is a registered broker/dealer headquartered in New York City. The firm is the U.S. arm of Toronto-based Canaccord Genuity Corp., the global capital markets division of Canaccord Financial, Inc. (CF: TSX / CF: AIM). Canaccord Genuity's research focuses on the following sectors of the global economy: metals/mining, energy, agriculture, technology, telecommunications, financials, consumer products, real estate, transportation, infrastructure, sustainability, life sciences, support services and investment trusts. Canaccord Genuity, Inc. is a member of FINRA/SIPC. | Corporate Officer/Principal | 01/01/2016 |
| Saisarva LLC | Founder | 01/01/2013 |
| Reliance Capital Usa Ventures LLC | Chief Investment Officer | 01/01/2009 |
Lordes Capital Ltd.
 Lordes Capital Ltd. Investment Banks/BrokersFinance Lordes Capital Ltd. offers fund management activities. The company was founded on September 20, 2005 and is headquartered in Kent, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Preetam Shah
| University of Mississippi Medical Center | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| CIDARA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Finance |
Lordes Capital Ltd.
Lordes Capital Ltd. Investment Banks/BrokersFinance Lordes Capital Ltd. offers fund management activities. The company was founded on September 20, 2005 and is headquartered in Kent, the United Kingdom. | Finance |
Canaccord Genuity, Inc.
Canaccord Genuity, Inc. Investment Banks/BrokersFinance Founded in 2006, Canaccord Genuity, Inc. is a registered broker/dealer headquartered in New York City. The firm is the U.S. arm of Toronto-based Canaccord Genuity Corp., the global capital markets division of Canaccord Financial, Inc. (CF: TSX / CF: AIM). Canaccord Genuity's research focuses on the following sectors of the global economy: metals/mining, energy, agriculture, technology, telecommunications, financials, consumer products, real estate, transportation, infrastructure, sustainability, life sciences, support services and investment trusts. Canaccord Genuity, Inc. is a member of FINRA/SIPC. | Finance |
| Reliance Capital Usa Ventures LLC | |
| Saisarva LLC |
